Home

Επιμένω Υποχρεωτικός Συναισθηματική kappa opioid receptor anxiety depression Ερεθίζω Ανεξάρτητα κρότος

Kappa opioid receptor signaling in the brain: Circuitry and implications  for treatment - ScienceDirect
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect

Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and  Psychiatric Disorders: Function and Implications
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications

IJMS | Free Full-Text | Stress-Induced Changes in the Endogenous Opioid  System Cause Dysfunction of Pain and Emotion Regulation
IJMS | Free Full-Text | Stress-Induced Changes in the Endogenous Opioid System Cause Dysfunction of Pain and Emotion Regulation

Opioid receptors: distinct roles in mood disorders | Semantic Scholar
Opioid receptors: distinct roles in mood disorders | Semantic Scholar

Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or  approach-avoidance behavior occur differentially across the nucleus  accumbens shell rostro-caudal axis - ScienceDirect
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect

The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology  of Schizophrenia: A Review of the Evidence
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

Dynorphin, stress, and depression | Semantic Scholar
Dynorphin, stress, and depression | Semantic Scholar

J Clin Med Res
J Clin Med Res

Biased agonists of the kappa opioid receptor suppress pain and itch without  causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling

Endogenous opioid system dysregulation in depression: implications for new  therapeutic approaches | Molecular Psychiatry
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry

Frontiers | A Trigger for Opioid Misuse: Chronic Pain and Stress  Dysregulate the Mesolimbic Pathway and Kappa Opioid System
Frontiers | A Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid System

Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for  the Development of Potential Treatments of Pain with Reduced Side Effects
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

Brain Sciences | Free Full-Text | Shared Mechanisms of GABAergic and  Opioidergic Transmission Regulate Corticolimbic Reward Systems and  Cognitive Aspects of Motivational Behaviors
Brain Sciences | Free Full-Text | Shared Mechanisms of GABAergic and Opioidergic Transmission Regulate Corticolimbic Reward Systems and Cognitive Aspects of Motivational Behaviors

The Kappa Opioid Receptor: From Addiction to Depression, and Back |  Semantic Scholar
The Kappa Opioid Receptor: From Addiction to Depression, and Back | Semantic Scholar

Chronic Kappa opioid receptor activation modulates NR2B: Implication in  treatment resistant depression – topic of research paper in Clinical  medicine. Download scholarly article PDF and read for free on CyberLeninka  open science
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science

Development of κ Opioid Receptor Antagonists | Journal of Medicinal  Chemistry
Development of κ Opioid Receptor Antagonists | Journal of Medicinal Chemistry

Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal  Treatment Potential of Buprenorphine
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine

A systematic review on the kappa opioid receptor and its ligands: New  directions for the treatment of pain, anxiety, depression, and drug abuse -  ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect

Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes  for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry

Role of kappa-opioid receptors in stress and anxiety-related behavior. -  Abstract - Europe PMC
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC

Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid  Receptor System in the Actions of Alcohol
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol

Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Scientists Take a Big Step toward Building a Better Opioid | Newsroom

Frontiers | A Review of the Therapeutic Potential of Recently Developed G  Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists

Frontiers | Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain  Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a  Rat Model of Functional Pain
Frontiers | Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain

Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class  of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink